News
Best Buy's Great Quarterly Results Get Overshadowed by a Question Mark
Despite posting positive numbers during the second quarter, shares of Best Buy (NYSE: BBY) are down double digits. It has been a great run for investors the last year, but the company warned that....
Strong Pickup Sales Were a Bright Spot for Ford in August
Ford Motor Company (NYSE: F) said its U.S. sales fell 2.1% in August. That was a smaller decline than analysts had expected. A big surge in sales of Ford's F-Series pickups helped to offset....
This Week in Solar
Earnings season is over and it seems most of the market is slowing down before the end of summer. But the solar industry continues to make news, both good and bad.This week, the industry showed....
3 REIT Stocks to Buy With Dividends Yielding More Than 6%
High yielding dividends often come with caution signs for investors because an unusually high dividend usually means the market doesn't think the payout will last. And if we were looking at....
How GE’s New Management Will Affect the Company’s Future
General Electric Company's (NYSE: GE) CEO Jeff Immelt is stepping down and handing the reins to the CEO of GE Healthcare John Flannery, and investors seem to have pretty split feelings about it.In....
Gilead Sciences’ Oncology M&A Strategy Explained
Gilead Sciences (NASDAQ: GILD) has wanted to be a leader in cancer treatment for awhile, and this week, it made a big splash into the indication when it announced the planned acquisition of Kite....
Gilead Sciences’ Oncology M&A Strategy Explained
Gilead Sciences (NASDAQ: GILD) has wanted to be a leader in cancer treatment for awhile, and this week, it made a big splash into the indication when it announced the planned acquisition of Kite....
Gilead Sciences’ Oncology M&A Strategy Explained
Gilead Sciences (NASDAQ: GILD) has wanted to be a leader in cancer treatment for awhile, and this week, it made a big splash into the indication when it announced the planned acquisition of Kite....
You Reached Retirement: 3 Stocks to Consider Today
There's a lot of attention dedicated to saving money leading up to your retirement, but the topic of putting your money to work once you're finally there is too often ignored. And even then, many....
You Reached Retirement: 3 Stocks to Consider Today
There's a lot of attention dedicated to saving money leading up to your retirement, but the topic of putting your money to work once you're finally there is too often ignored. And even then, many....
You Reached Retirement: 3 Stocks to Consider Today
There's a lot of attention dedicated to saving money leading up to your retirement, but the topic of putting your money to work once you're finally there is too often ignored. And even then, many....
You Reached Retirement: 3 Stocks to Consider Today
There's a lot of attention dedicated to saving money leading up to your retirement, but the topic of putting your money to work once you're finally there is too often ignored. And even then, many....
Why L Brands, Conn's, and lululemon athletica Jumped Today
The major benchmarks added to their gains for the week on a positive but quiet day on Wall Street. Jobs growth slowed during August, with employers adding 156,000 jobs for the month, lower than....
Why L Brands, Conn's, and lululemon athletica Jumped Today
The major benchmarks added to their gains for the week on a positive but quiet day on Wall Street. Jobs growth slowed during August, with employers adding 156,000 jobs for the month, lower than....
Why Snap, Tech Data, and Ambarella Slumped Today
Friday was a positive day for the stock market, as the major benchmarks built on gains achieved over the last several trading sessions. Investors seemed to shrug off news that job growth slowed in....
Why Snap, Tech Data, and Ambarella Slumped Today
Friday was a positive day for the stock market, as the major benchmarks built on gains achieved over the last several trading sessions. Investors seemed to shrug off news that job growth slowed in....
Why Snap, Tech Data, and Ambarella Slumped Today
Friday was a positive day for the stock market, as the major benchmarks built on gains achieved over the last several trading sessions. Investors seemed to shrug off news that job growth slowed in....
Wonder Why Gilead Sciences Bought Kite Pharma? Here’s the Answer!
The next big thing in cancer treatment could be chimeric-antigen receptor T-cell therapy, or CAR-T, a novel approach that uncloaks cancer cells so that the immune system can destroy them. The....
Wonder Why Gilead Sciences Bought Kite Pharma? Here’s the Answer!
The next big thing in cancer treatment could be chimeric-antigen receptor T-cell therapy, or CAR-T, a novel approach that uncloaks cancer cells so that the immune system can destroy them. The....
Wonder Why Gilead Sciences Bought Kite Pharma? Here’s the Answer!
The next big thing in cancer treatment could be chimeric-antigen receptor T-cell therapy, or CAR-T, a novel approach that uncloaks cancer cells so that the immune system can destroy them. The....
Intel Gets a Jump in the Notebook Market With Its New Chips
Intel (NASDAQ: INTC) has been taking a lot of heat from Advanced Micro Devices (NASDAQ: AMD) in the CPU (central processing unit) space. AMD's Ryzen CPUs have taken the market by storm and,....
Intel Gets a Jump in the Notebook Market With Its New Chips
Intel (NASDAQ: INTC) has been taking a lot of heat from Advanced Micro Devices (NASDAQ: AMD) in the CPU (central processing unit) space. AMD's Ryzen CPUs have taken the market by storm and,....
Intel Gets a Jump in the Notebook Market With Its New Chips
Intel (NASDAQ: INTC) has been taking a lot of heat from Advanced Micro Devices (NASDAQ: AMD) in the CPU (central processing unit) space. AMD's Ryzen CPUs have taken the market by storm and,....
Intel Gets a Jump in the Notebook Market With Its New Chips
Intel (NASDAQ: INTC) has been taking a lot of heat from Advanced Micro Devices (NASDAQ: AMD) in the CPU (central processing unit) space. AMD's Ryzen CPUs have taken the market by storm and,....
Why J.M. Smucker Stock Lost 14% in August
Packaged foods specialist J.M. Smucker (NYSE: SJM) shed 14% last month, according to data provided by S&P Global Market Intelligence.The decline pushed the stock to lows that shareholders....